Crinetics launches ACRO/TRUTH educational initiative

Crinetics Pharmaceuticals announced the launch of the ACRO/TRUTH healthcare provider, HCP, educational website and initiative, the purpose of which is to spotlight the significant challenges and burdens many people living with acromegaly experience when managing their disease with the current standard-of-care, injectable somatostatin receptor ligands, SRLs. “People living with acromegaly still experience diminished quality of life due to their disease and to the limitations of the treatment options currently available to treat their disease,” said Alan Krasner, M.D., Chief Endocrinologist at Crinetics. “Crinetics is dedicated to bringing forward innovative products to better the lives of patients, and an integral part of that mission is bringing the patient perspective to the forefront.”